New hope for AML patients in india: drug combo aims for remission without intensive chemo

NCT ID NCT07044687

Recruiting now Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study tests a combination of two drugs, venetoclax and azacitidine, in about 100 adults in India with newly diagnosed acute myeloid leukemia (AML) who are not healthy enough for standard intensive chemotherapy. The goal is to see if the combo can put the cancer into remission and to track side effects. Participants take venetoclax pills daily and receive azacitidine injections for a week each cycle, with regular checkups over about 29 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myeloid leukemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE MYELOID LEUKEMIA

Contacts and locations

Locations

All India Institute Of Medical Sciences - Bhubaneswar /ID# 274879
RECRUITING

Bhubaneswar, Odisha, 751019, India
All India Institute Of Medical Sciences - New Delhi /ID# 268357
RECRUITING

New Delhi, National Capital Territory of Delhi, 110029, India
Apollo Cancer Centre /ID# 268780
RECRUITING

Chennai, Tamil Nadu, 600035, India
Basavatarakam Indo American Cancer Hospital & Research Institute /ID# 268692
RECRUITING

Hyderabad, Telangana, 500034, India
Cancer Institute (Wia) /ID# 268695
RECRUITING

Chennai, Tamil Nadu, 600036, India
Fortis Memorial Research Institute /ID# 268697
RECRUITING

Gurgaon, Haryana, 122002, India
Healthcare Global Enterprises Limited (HCGEL) /ID# 272071
COMPLETED

Bengaluru, Karnataka, 560027, India
LMMF's Deenanath Mangeshkar Hospital & Research Center /ID# 268781
RECRUITING

Pune, Maharashtra, 411004, India
Mazumdar Shaw Medical Center /ID# 270677
RECRUITING

Bengaluru, Karnataka, 560099, India
Rajiv Gandhi Cancer Institute And Research Centre /ID# 268293
RECRUITING

New Delhi, National Capital Territory of Delhi, 110085, India
Regional Cancer Centre /ID# 268785
RECRUITING

Thiruvananthapuram, Kerala, 695011, India
Sahyadri Super Speciality Hospital /ID# 272074
RECRUITING

Pune, Maharashtra, 411044, India
Tata Memorial Hospital - Mumbai /ID# 269177
RECRUITING

Mumbai, Maharashtra, 400012, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.